United Kingdom

Foundation Medicine Inc (FMI.OQ)

FMI.OQ on NASDAQ Stock Exchange Global Select Market

8:59pm GMT
Change (% chg)

$-3.30 (-4.92%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Foundation Medicine Q3 loss per share $0.90
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Foundation Medicine Inc :Foundation Medicine announces 2017 third quarter results and recent highlights.Q3 loss per share $0.90.Sees FY 2017 revenue $135 million to $145 million.Q3 revenue $42.7 million versus I/B/E/S view $38 million.Q3 earnings per share view $-1.10 -- Thomson Reuters I/B/E/S.  Full Article

Foundation Medicine Inc - FoundationOne accepted by FDA and CMS for Parallel Review and FDA Expedited Access Pathway
Tuesday, 2 Aug 2016 

Foundation Medicine Inc : FoundationOne® accepted by FDA and CMS for parallel review and FDA expedited access pathway . FDA also accepted foundation medicine's request for review as part of its Expedited Access Pathway (EAP) for breakthrough devices .Foundation Medicine Inc says based on discussions with FDA and CMS, Foundation Medicine believes parallel review will conclude in second half of 2017.  Full Article

Foundation Medicine Inc gives FY 2016 revenue guidance
Tuesday, 23 Feb 2016 

Foundation Medicine Inc:Expects FY 2016 revenue will be in the range of $110 to $120 million.  Full Article

Swiss stocks - Factors to watch on Dec 4

ZURICH, Dec 4 The Swiss blue-chip SMI was seen opening 1 percent higher at 9,365 points on Monday, according to premarket indications by bank Julius Baer .